ABEO: Abeona Therapeutics Inc. insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 4 sales totaling $208K in the last 180 days.

Insider sales

Trade dateInsiderRoleValue10b5-1 plan
2026-09-29Seshadri VishwasCEO$101K
2026-09-29Vazzano Joseph WalterCFO$47K
2026-09-29O'Malley Brendan M.Officer$35K
2026-09-29Vasanthavada MadhavOfficer$25K

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-14Fell below 5%Montanova Capital, LLC0.90%SEC

Institutional ownership (Q2 2026)

126 institutions reported holding $274.55M of Abeona Therapeutics Inc. on Form 13F (108 the quarter before). 29 opened a new position and 12 sold out. Shares held by institutions: +13%.

Largest holdersSharesValue
Nantahala Capital Management, LLC10,272,980$63.49M
BlackRock, Inc.3,352,474$20.72M
Cable Car Capital, LP3,007,329$18.59M
AIGH Capital Management LLC2,987,000$18.46M
VANGUARD CAPITAL MANAGEMENT LLC2,211,433$13.67M
OneDigital Investment Advisors LLC1,653,024$10.22M
AWM Investment Company, Inc.1,486,130$9.18M
GEODE CAPITAL MANAGEMENT, LLC1,261,090$7.80M
KENNEDY CAPITAL MANAGEMENT LLC1,240,071$7.66M
GOLDMAN SACHS GROUP INC1,224,806$7.57M

Get new insider and activist filings the morning after: daily alerts. Not investment advice.